Table A3.
Fitted Multivariable Logistic Regression Model for Complete Remission
| Variable | Coefficient | SE | Odds Ratio | P |
|---|---|---|---|---|
| All variables included, n = 567 | ||||
| (Intercept) | 1.26 | 0.53 | — | .02 |
| Age | −0.02 | 0.01 | 0.98 | .03 |
| Ln(β-2M) | −0.89 | 0.25 | 0.41 | < .001 |
| Regimen = FC/FM (v fludarabine) | 0.34 | 0.30 | 1.40 | .26 |
| Regimen = FCR (v fludarabine) | 2.04 | 0.27 | 7.71 | < .001 |
| Excluding treatment regimen, n = 471 | ||||
| Intercept | 0.03 | 1.02 | — | .98 |
| Age | −0.02 | 0.01 | 0.98 | .05 |
| Ln(β-2M) | −0.67 | 0.27 | 0.51 | .02 |
| HGB | 0.12 | 0.06 | 1.12 | .04 |
| Ln(BM prolymphocytes) | 0.63 | 0.12 | 1.88 | < .001 |
Abbreviations: Ln, natural log; β-2M, β2 microglobulin; FC, fludarabine with cyclophosphamide; FM, fludarabine with mitoxantrone; FCR, fludarabine, cyclophosphamide, and rituximab; HGB, hemoglobin; BM, bone marrow.